Literature DB >> 35925141

[Surgery of hyperparathyroidism].

Martina T Mogl1,2, Peter E Goretzki3.   

Abstract

The surgical removal of diseased parathyroid glands is the only curative treatment for primary and secondary hyperparathyroidism. Before an intervention, the confirmed diagnosis and an accurate localization are decisive for selection of the appropriate procedure. After appropriate localization diagnostics, a focussed intervention is possible for primary hyperparathyroidism, whereby every intervention must be controlled by intraoperative monitoring of parathyroid hormone. Reoperations or multiple glandular disease necessitate a differentiated approach with appropriate prior diagnostics.
© 2022. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Diagnostics; Hyperparathyroidism; Multiple glandular disease; Recurrence; Treatment

Year:  2022        PMID: 35925141     DOI: 10.1007/s00104-022-01652-5

Source DB:  PubMed          Journal:  Chirurgie (Heidelb)        ISSN: 2731-6971


  23 in total

1.  Epidemiology of primary hyperparathyroidism in Europe.

Authors:  Silvano Adami; Claudio Marcocci; Davide Gatti
Journal:  J Bone Miner Res       Date:  2002-11       Impact factor: 6.741

2.  Neuropsychiatric and cognitive changes after surgery for primary hyperparathyroidism.

Authors:  Cornelia M E Dotzenrath; Ana Karena Kaetsch; Henrich Pfingsten; Kenko Cupisti; Norbert Weyerbrock; Alexander Vossough; Pablo E Verde; Christian Ohmann
Journal:  World J Surg       Date:  2006-05       Impact factor: 3.352

Review 3.  Secondary Hyperparathyroidism: Pathogenesis and Latest Treatment.

Authors:  Masahide Mizobuchi; Hiroaki Ogata; Fumihiko Koiwa
Journal:  Ther Apher Dial       Date:  2018-12-18       Impact factor: 1.762

4.  Calcium-sensing receptor expression and parathyroid hormone secretion in hyperplastic parathyroid glands from humans.

Authors:  Sagrario Cañadillas; Antonio Canalejo; Rafael Santamaría; Maria E Rodríguez; Jose C Estepa; Alejandro Martín-Malo; Juan Bravo; Blanca Ramos; Escolastico Aguilera-Tejero; Mariano Rodríguez; Yolanda Almadén
Journal:  J Am Soc Nephrol       Date:  2005-05-11       Impact factor: 10.121

5.  Incidence and prevalence of primary hyperparathyroidism in a racially mixed population.

Authors:  Michael W Yeh; Philip H G Ituarte; Hui Cynthia Zhou; Stacie Nishimoto; In-Lu Amy Liu; Avital Harari; Philip I Haigh; Annette L Adams
Journal:  J Clin Endocrinol Metab       Date:  2013-02-15       Impact factor: 5.958

Review 6.  Parathyroid Carcinoma.

Authors:  Filomena Cetani; Elena Pardi; Claudio Marcocci
Journal:  Front Horm Res       Date:  2018-11-19       Impact factor: 2.606

7.  Rates and Outcomes of Parathyroidectomy for Secondary Hyperparathyroidism in the United States.

Authors:  Sun Moon Kim; Jin Long; Maria E Montez-Rath; Mary B Leonard; Jeffrey A Norton; Glenn M Chertow
Journal:  Clin J Am Soc Nephrol       Date:  2016-06-06       Impact factor: 8.237

8.  Increasing incidence of primary hyperparathyroidism in Denmark.

Authors:  Ali Abood; Peter Vestergaard
Journal:  Dan Med J       Date:  2013-02       Impact factor: 1.240

9.  Neuropsychological features in primary hyperparathyroidism: a prospective study.

Authors:  Marcella D Walker; Donald J McMahon; William B Inabnet; Ronald M Lazar; Ijeoma Brown; Susan Vardy; Felicia Cosman; Shonni J Silverberg
Journal:  J Clin Endocrinol Metab       Date:  2009-03-31       Impact factor: 5.958

10.  Asymptomatic secondary hyperparathyroidism can mimic sacroiliitis on computed tomography.

Authors:  Virginie Kreutzinger; Torsten Diekhoff; Lutz Liefeldt; Denis Poddubnyy; Kay Geert A Hermann; Katharina Ziegeler
Journal:  Sci Rep       Date:  2021-02-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.